Dropped head sign induced by transdermal application of the dopamine agonist rotigotine in parkinsonian syndrome: a case report

2013 | journal article

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Dropped head sign induced by transdermal application of the dopamine agonist rotigotine in parkinsonian syndrome: a case report​
Dohm, C. P. ; Gröschel, S.; Liman, J. ; Bähr, M.   & Kermer, P. ​ (2013) 
Journal of Medical Case Reports7(1) art. 174​.​ DOI: https://doi.org/10.1186/1752-1947-7-174 

Documents & Media

1752-1947-7-174-S1.PDF276.86 kBAdobe PDF1752-1947-7-174.pdf183.2 kBAdobe PDF1752-1947-7-174-S2.PDF265.52 kBAdobe PDF


Published Version

Attribution 2.0 CC BY 2.0


Dohm, Christoph P. ; Gröschel, Sonja; Liman, Jan ; Bähr, Mathias ; Kermer, Pawel 
Introduction ‘Dropped head sign’ relates to a severe disproportionate antecollis in parkinsonism. We present the first report of a rotigotine-induced dropped head sign in a patient with suspected idiopathic Parkinson’s disease, which was later defined as multiple system atrophy. The ‘dropped head sign’ is considered a rare symptom of unknown etiology in parkinsonian disorders, though a disproportionate antecollis is frequently observed in multiple system atrophy. It has also been described as a side effect of dopamine agonist medication with cabergoline and pramipexole. Rotigotine is a transdermally applied, non-ergot dopamine agonist, resulting in a continuous stimulation of dopamine receptors, which is widely used in the treatment of patients with Parkinson’s disease. Case presentation We report a case of a 64-year-old Caucasian woman with a rapidly progressive two-and-a-half-year history of a hypokinetic Parkinson’s syndrome with asymmetric development of symptoms and an initially good response to levodopa medication. Due to side effects of other dopamimetic medications the patient was switched to rotigotine medication five weeks before clinical admission. Progressive antecollis without muscle weakness and prominent paraspinal muscle contraction developed within two weeks of treatment and resolved within a week after discontinuation of rotigotine and initiation of levodopa/cabergoline medication. Conclusion While the pathophysiology still remains unresolved, this case supports the concept of a dopaminergic imbalance as a cause of certain axial dystonias like disproportionate antecollis including the ‘dropped head sign’. We believe this case is specifically useful for neurologists and general practitioners, as the easily recognizable symptom should prompt a thorough reevaluation of diagnosis and medication in patients with Parkinson’s disease.
Issue Date
Journal of Medical Case Reports 
1752-1947; 1752-1947



Social Media